Haleon plc (HLN.L)
Haleon is a global consumer healthcare giant that owns familiar household brands like Sensodyne, Panadol, and Centrum.
Is Haleon plc a good stock for a UK beginner?
The honest version: Haleon is a global consumer healthcare giant that owns familiar household brands like Sensodyne, Panadol, and Centrum.
Over about 2 years to 2026-07-31. This is the share price only - reinvesting the dividends would add to it. Past performance is not a guide to the future, and it could just as easily have fallen.
Based on beta - how much the price swings versus the whole market. Bumpier isn't bad; it just means a rougher ride, which matters more the sooner you might need the money.
Prices move on results, news and the mood of the whole market - no single headline explains a day, and a quiet week is usually just noise, not a signal.
Innovation in new health products leads to significant market share gains.
Major regulatory changes or legal challenges impact core product lines.
What does Haleon plc do?
Haleon makes its money by selling everyday health and wellness products that people pick up at the pharmacy or supermarket. Because these are essential items, the business tends to be quite steady regardless of what the wider economy is doing. How well they grow sales while taming the costs of a sprawling global supply chain is what to keep in view.
On our factor screen it looks strongest on quality and income, and weakest on value.
- ✓Pays a dividend - about 2.0% a year
- ✓Growing - revenue up about 2% over the year
- Owns a portfolio of highly recognisable, trusted household brands.
- Business model is generally resilient to economic downturns.
- High gross margins indicate strong pricing power for their products.
- Value screens low (31/100)
- Potential for supply chain disruptions affecting product availability.
- Changes in healthcare regulations could impact how products are sold.
- Rising costs of raw materials could eat into profit margins.
What do Haleon plc's numbers mean?
Does Haleon plc pay a dividend?
Yes - Haleon plc currently pays a dividend of about 2.0% a year (the yearly payout as a share of the price). A dividend is a slice of profit handed to shareholders; the yield moves as the price moves, and a company can cut or stop it.
More in Healthcare
Eli Lilly
West Pharmaceutical Services, Inc.
Incyte Corporation
The Cigna Group
Zimmer Biomet Holdings, Inc.
Moderna, Inc.
Gilead Sciences, Inc.
Regeneron Pharmaceuticals, Inc.What are the scenarios for Haleon plc?
An illustrative range for the year ahead, with the assumption behind each case — not a prediction or a price target.
What are the pros and cons of Haleon plc?
How many points the write-up makes each way — a balance check, not a score or verdict.
- Owns a portfolio of highly recognisable, trusted household brands.
- Business model is generally resilient to economic downturns.
- High gross margins indicate strong pricing power for their products.
- Revenue growth has been relatively flat recently.
- Faces constant pressure from cheaper supermarket own-label products.
- Large scale can make it difficult to achieve rapid growth.
- Potential for supply chain disruptions affecting product availability.
- Changes in healthcare regulations could impact how products are sold.
- Rising costs of raw materials could eat into profit margins.
The write-up's own warning lights — if these start happening, the case above changes.
- A sustained period of declining revenue across major brands.
- A significant, permanent drop in profit margins due to rising costs.
Built from public filings & market prices, checked for an education-only tone, and never a price target. How we make these →
This plain-English summary was auto-generated on 2026-08-01 from public data and checked for an education-only, no-advice tone (the figures above carry their own, usually fresher, 'as of' date). It's information, never a recommendation.